The DOI matches its Crossref record; 160 of the 160 references it cites were found in a registry or an index.
Energy metabolism in tumor cells
Abstract
In early studies on energy metabolism of tumor cells, it was proposed that the enhanced glycolysis was induced by a decreased oxidative phosphorylation. Since then it has been indiscriminately applied to all types of tumor cells that the ATP supply is mainly or only provided by glycolysis, without an appropriate experimental evaluation. In this review, the different genetic and biochemical mechanisms by which tumor cells achieve an enhanced glycolytic flux are analyzed. Furthermore, the proposed mechanisms that arguably lead to a decreased oxidative phosphorylation in tumor cells are discussed. As the O 2 concentration in hypoxic regions of tumors seems not to be limiting for the functioning of oxidative phosphorylation, this pathway is re‐evaluated regarding oxidizable substrate utilization and its contribution to ATP supply versus glycolysis. In the tumor cell lines where the oxidative metabolism prevails over the glycolytic metabolism for ATP supply, the flux control distribution of both pathways is described. The effect of glycolytic and mitochondrial drugs on tumor energy metabolism and cellular proliferation is described and discussed. Similarly, the energy metabolic changes associated with inherent and acquired resistance to radiotherapy and chemotherapy of tumor cells, and those determined by positron emission tomography, are revised. It is proposed that energy metabolism may be an alternative therapeutic target for both hypoxic (glycolytic) and oxidative tumors.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Warburg, O. (1956) · Science · doi:10.1126/science.123.3191.309 · Cited by 13,425
Why Do Cancers Have High Aerobic Glycolysis?
Gatenby, R. A., & Gillies, R. J. (2004) · Nature reviews. Cancer · doi:10.1038/nrc1478 · Cited by 4,784
On Respiratory Impairment in Cancer Cells
Warburg, O. (1956) · Science · doi:10.1126/science.124.3215.269 · Cited by 3,468
(1989) · PubMed · Cited by 3,343
HIF-1: mediator of physiological and pathophysiological responses to hypoxia
Semenza, G. L. (2000) · Journal of Applied Physiology · doi:10.1152/jappl.2000.88.4.1474 · Cited by 1,822
Cell and environment interactions in tumor microregions: the multicell spheroid model.
Sutherland, R. M. (1988) · Science · doi:10.1126/science.2451290 · Cited by 1,803
p53 Regulates Mitochondrial Respiration
Matoba, S., Kang, J.-G., Patino, W. D., Wragg, A., Boehm, M., Gavrilova, O., Hurley, P. J., Bunz, F., & Hwang, P. M. (2006) · Science · doi:10.1126/science.1126863 · Cited by 1,650
Fantin, V. R., St-Pierre, J., & Leder, P. (2006) · Cancer Cell · doi:10.1016/j.ccr.2006.04.023 · Cited by 1,635
Evidence that glutamine, not sugar, is the major energy source for cultured HeLa cells.
Reitzer, L. J., Wice, B. M., & Kennell, D. (1979) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)30124-2 · Cited by 1,240
Understanding the control of metabolism
(1997) · Choice Reviews Online · doi:10.5860/choice.34-6252 · Cited by 1,231
Research works printed but not linked: 38
- 10.1023/A:1012493232344 · doi:10.1023/a:1012493232344
- 10.1111/j.1471-4159.1983.tb09043.x · doi:10.1111/j.1471-4159.1983.tb09043.x
- Dastidar SG, 1989, Activities of glycolytic enzymes in rapidly proliferating and differentiated C6 glioma cells, Exp Cell Biol, 57, 159
- 10.1016/0006-291X(86)90382-7 · doi:10.1016/0006-291x(86)90382-7
- 10.1042/bj1580439 · doi:10.1042/bj1580439
- 10.1042/bj1830055 · doi:10.1042/bj1830055
- 10.1042/bj1900705 · doi:10.1042/bj1900705
- 10.1007/BF00926073 · doi:10.1007/bf00926073
- 10.1126/science.134.3489.1495 · doi:10.1126/science.134.3489.1495
- LaNoue KF, 1974, Hormones and Cancer, 131
- 10.1093/jnci/56.1.65 · doi:10.1093/jnci/56.1.65
- 10.3171/jns.1987.67.3.0336 · doi:10.3171/jns.1987.67.3.0336
- Barbour RL, 1983, Adenine nucleotide transport in hepatoma mitochondria and its correlation with hepatoma growth rates and tumor size, Cancer Res, 43, 1511
- White MT, 1973, Structural and functional changes in Novikoff hepatoma mitochondria, Cancer Res, 33, 1645
- 10.1002/jcp.1040930218 · doi:10.1002/jcp.1040930218
- 10.1016/0014-5793(92)81427-N · doi:10.1016/0014-5793(92)81427-n
- 10.1002/(SICI)1099-0844(199806)16:2<99::AID-CBF773>3.0.CO;2-2 · doi:10.1002/(sici)1099-0844(199806)16:2<99::aid-cbf773>3.0.co;2-2
- 10.1016/0020-711X(90)90145-S · doi:10.1016/0020-711x(90)90145-s
- 10.1158/0008-5472.CAN-04-4313 · DOI
- Thews O, 1998, Blood flow, oxygenation, metabolic and energetic status in different clonal subpopulations of a rat rhabdomyosarcoma, Int J Oncol, 13, 205
- Inoue M, 2004, Targeting hypoxic cancer cells with a protein prodrug is effective in experimental malignant ascites, Int J Oncol, 25, 713
- Nielsen FU, 2001, Effect of changing tumor oxygenation on glycolytic metabolism in a murine C3H mammary carcinoma assessed by in vivo nuclear magnetic resonance spectroscopy, Cancer Res, 61, 5318
- 10.1002/jcp.1041030121 · doi:10.1002/jcp.1041030121
- Fearon KC, 1987, Reduction of the growth rate of the Walker 256 tumor in rats by rhodamine 6G together with hypoglycemia, Cancer Res, 47, 3684
- Fanciulli M, 1996, Effect of the antitumor drug lonidamine on glucose metabolism of adriamycin‐sensitive and ‐resistant human breast cancer cells, Oncol Res, 8, 111
- Cahlin C, 2005, The effects of non‐selective, preferential‐selective and selective COX‐inhibitors on the growth of experimental and human tumors in mice related to protanoid receptors, Int J Oncol, 27, 913
- 10.1006/abbi.1995.1314 · doi:10.1006/abbi.1995.1314
- Navolanic PM, 2005, Pharmacological breast cancer therapy (review), Int J Oncol, 27, 1341
- 10.1046/j.1365-2141.1996.d01-1951.x · doi:10.1046/j.1365-2141.1996.d01-1951.x
- 10.1097/01.mnm.0000136693.94761.5c · doi:10.1097/01.mnm.0000136693.94761.5c
- 10.1007/BF03164593 · doi:10.1007/bf03164593
- 10.1007/BF03165001 · doi:10.1007/bf03165001
- Rodrigues M, 2002, Accumulation of TC‐99M‐MIBI and TC‐99M‐Tetrofosmin in tumor cells. Uptake and washout studies, AloSbimn J, 17, 410
- 10.1053/j.semnuclmed.2005.09.001 · doi:10.1053/j.semnuclmed.2005.09.001
- 10.1155/MBD.2001.19 · doi:10.1155/mbd.2001.19
- Ziegler A, 2001, High glycolytic activity in rat glioma demonstrated in vivo by correlation peak 1H magnetic resonance imaging, Cancer Res, 61, 5595
- Fanciulli M, 1993, Glucose metabolism in adriamycin‐sensitive and ‐resistant LoVo human colon carcinoma cells, Oncol Res, 5, 357
- Elwood JC, 1963, Glucose utilization in homogenates of the Morris hepatoma 5123 and related tumors, Cancer Res, 23, 906
Cited by
Understanding the Warburg Effect: The Metabolic Requirements of Cell Proliferation
Vander Heiden, M. G., Cantley, L. C., & Thompson, C. B. (2009) · Science · doi:10.1126/science.1160809 · Cited by 16,197
Regulation of cancer cell metabolism
Cairns, R. A., Harris, I. S., & Mak, T. W. (2011) · Nature Reviews Cancer · doi:10.1038/nrc2981 · Cited by 4,744
The Biology of Cancer: Metabolic Reprogramming Fuels Cell Growth and Proliferation
DeBerardinis, R. J., Lum, J. J., Hatzivassiliou, G., & Thompson, C. B. (2008) · Cell Metabolism · doi:10.1016/j.cmet.2007.10.002 · Cited by 4,088
Aerobic glycolysis: Meeting the metabolic requirements of cell proliferation
Lunt, S. Y., & Vander Heiden, M. G. (2011) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev-cellbio-092910-154237 · Cited by 3,057
Glutamine addiction: a new therapeutic target in cancer
Wise, D. R., & Thompson, C. B. (2010) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2010.05.003 · Cited by 1,770
Metadata
- Authors
- Moreno‐Sánchez, R., Rodríguez‐Enríquez, S., Marín‐Hernández, A., & Saavedra, E.
- Venue
- The FEBS Journal
- Publisher
- Wiley
- Published
- 2007-02-14
- Volume
- 274
- Issue
- 6
- Pages
- 1393-1418
- ISSN
- 1742-464X (ISSN-L)
- 1742-4658
- OpenAlex
- W2161128788
- Cited by
- 1,082
- References
- 160
- FWCI
- 13.18
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Energy metabolism in tumor cells. https://app.cochat.ai/papers/10.1111/j.1742-4658.2007.05686.x
- The paper
- Moreno‐Sánchez, R., Rodríguez‐Enríquez, S., Marín‐Hernández, A., & Saavedra, E. (2007). Energy metabolism in tumor cells. The FEBS Journal. https://doi.org/10.1111/j.1742-4658.2007.05686.x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.
